BackAN2 Therapeutics Overview

AN2 Therapeutics Minority Interest

Latest minority interest for ANTX: $0.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$0.00

Peer average / median

Loading

AN2 Therapeutics Minority Interest History

Loading

AN2 Therapeutics vs. peers: Minority Interest Comparison

Loading

AN2 Therapeutics Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AN2 Therapeutics (ANTX) FAQ

AN2 Therapeutics (ANTX) currently reports a minority interest of $0 as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore AN2 Therapeutics's minority interest history and peer comparisons.

AN2 Therapeutics's minority interest changed from $0 to $0 (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

AN2 Therapeutics reported $0 in minority interest as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current minority interest of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for AN2 Therapeutics, and consider following ANTX for alerts when major investors trade the stock.